Cargando…
ADAM17 Activity and IL-6 Trans-Signaling in Inflammation and Cancer
All ligands of the epidermal growth factor receptor (EGF-R) are transmembrane proteins, which need to be proteolytically cleaved in order to be systemically active. The major protease responsible for this cleavage is the membrane metalloprotease ADAM17, which also has been implicated in cleavage of...
Autores principales: | Schumacher, Neele, Rose-John, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895846/ https://www.ncbi.nlm.nih.gov/pubmed/31694340 http://dx.doi.org/10.3390/cancers11111736 |
Ejemplares similares
-
ADAM-Mediated Signalling Pathways in Gastrointestinal Cancer Formation
por: Schumacher, Neele, et al.
Publicado: (2020) -
ADAM17 is required for EGF-R–induced intestinal tumors via IL-6 trans-signaling
por: Schmidt, Stefanie, et al.
Publicado: (2018) -
ADAM17 selectively activates the IL‐6 trans‐signaling/ERK MAPK axis in KRAS‐addicted lung cancer
por: Saad, Mohamed I, et al.
Publicado: (2019) -
IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
por: Rose-John, Stefan
Publicado: (2012) -
ADAM17: An Emerging Therapeutic Target for Lung Cancer
por: Saad, Mohamed I., et al.
Publicado: (2019)